By Paulick Report Staff
The Louisiana Racing Commission accepted the Racing Medication Testing Consortium’s model rules for medication at a meeting on Monday, according to a report from the Daily Racing Form. The rules will go into effect for Thoroughbreds beginning in October.
The process of adopting the rules took about nine months as the commission announced its intent to adopt the rules last November and opened the issue to public comment.
The rules, which have already been accepted in part or in full by 15 other states, guide the use of 26 therapeutic medications deemed acceptable to use in racing Thoroughbreds, along with established thresholds intended to prevent those medications from altering performance. Furosemide is the only drug permitted to be administered on race day.
For Louisiana racing, the rule adoption will tighten rules guiding the use of anti-inflammatory drugs and clenbuterol, among other changes.